Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Parathyroid Glands00:59

The Parathyroid Glands

3.3K
The two pairs of parathyroid glands embedded within the posterior surface of the thyroid gland are restricted by a dense capsule around them. These glands comprise two distinct cell populations—parathyroid oxyphil and parathyroid principal cells- pivotal in calcium homeostasis.
Oxyphil cells, whose functions remain elusive, emerge during late puberty, adding a layer of complexity to the parathyroid gland's intricacies. In contrast, principal parathyroid cells undertake a vital role by...
3.3K
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

3.3K
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
3.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association Between Vitamin D Levels During Pregnancy and Postpartum Depression.

The Journal of pharmacy technology : jPT : official publication of the Association of Pharmacy Technicians·2021
Same author

Effects of concomitant combination of SGLT-2 inhibitor and GLP-1 receptor agonist on renal outcomes in T2D with eGFR below 30 and macroalbuminuria: A case series.

Clinical case reports·2021
Same author

Liraglutide treatment in overweight and obese patients with type 1 diabetes: A 26-week randomized controlled trial; mechanisms of weight loss.

Diabetes, obesity & metabolism·2020
Same author

Testosterone Increases the Expression and Phosphorylation of AMP Kinase α in Men With Hypogonadism and Type 2 Diabetes.

The Journal of clinical endocrinology and metabolism·2019
Same author

Effect of Testosterone on FGF2, MRF4, and Myostatin in Hypogonadotropic Hypogonadism: Relevance to Muscle Growth.

The Journal of clinical endocrinology and metabolism·2019
Same author

Addition of glucagon-like peptide-1 receptor agonist therapy to insulin in C-peptide-positive patients with type 1 diabetes.

Diabetes, obesity & metabolism·2018

Related Experiment Video

Updated: Nov 13, 2025

Establishment of a Simple and Effective Rat Model for Intraoperative Parathyroid Gland Imaging
07:12

Establishment of a Simple and Effective Rat Model for Intraoperative Parathyroid Gland Imaging

Published on: August 17, 2022

4.2K

Pembrolizumab-Associated Hypoparathyroidism: A Single Case Report.

Israa Mahmood1, Nitesh D Kuhadiya2, Michael Gonzalaes1

  • 1Division of Endocrinology, Diabetes and Metabolism, Renown Health, Reno, Nevada.

AACE Clinical Case Reports
|March 15, 2021
PubMed
Summary

Pembrolizumab therapy can cause immune-mediated hypoparathyroidism, leading to hypocalcemia. Early recognition and treatment of this side effect are crucial for patient recovery.

Keywords:
PTH, parathyroid hormonehypocalcemiahypoparathyroidismpembrolizumab

More Related Videos

Generation of Hypoparathyroid Rats via Carbon-Nanoparticle-Assisted Parathyroidectomy
03:57

Generation of Hypoparathyroid Rats via Carbon-Nanoparticle-Assisted Parathyroidectomy

Published on: July 14, 2023

2.1K
Two Techniques to Create Hypoparathyroid Mice: Parathyroidectomy Using GFP Glands and Diphtheria-Toxin-Mediated Parathyroid Ablation
07:13

Two Techniques to Create Hypoparathyroid Mice: Parathyroidectomy Using GFP Glands and Diphtheria-Toxin-Mediated Parathyroid Ablation

Published on: March 14, 2017

14.9K

Related Experiment Videos

Last Updated: Nov 13, 2025

Establishment of a Simple and Effective Rat Model for Intraoperative Parathyroid Gland Imaging
07:12

Establishment of a Simple and Effective Rat Model for Intraoperative Parathyroid Gland Imaging

Published on: August 17, 2022

4.2K
Generation of Hypoparathyroid Rats via Carbon-Nanoparticle-Assisted Parathyroidectomy
03:57

Generation of Hypoparathyroid Rats via Carbon-Nanoparticle-Assisted Parathyroidectomy

Published on: July 14, 2023

2.1K
Two Techniques to Create Hypoparathyroid Mice: Parathyroidectomy Using GFP Glands and Diphtheria-Toxin-Mediated Parathyroid Ablation
07:13

Two Techniques to Create Hypoparathyroid Mice: Parathyroidectomy Using GFP Glands and Diphtheria-Toxin-Mediated Parathyroid Ablation

Published on: March 14, 2017

14.9K

Area of Science:

  • Oncology
  • Endocrinology
  • Immunology

Background:

  • Pembrolizumab is an immune checkpoint inhibitor used in cancer therapy.
  • Hypoparathyroidism is a condition characterized by insufficient parathyroid hormone production, leading to low calcium levels.
  • Immune-related adverse events are known complications of immunotherapy.

Observation:

  • A patient receiving pembrolizumab for lung adenocarcinoma developed hypocalcemia.
  • Diagnostic tests revealed low parathyroid hormone levels, indicating hypoparathyroidism.
  • Genetic analysis ruled out a hereditary cause for the condition.

Findings:

  • Pembrolizumab treatment was associated with the development of hypoparathyroidism.
  • The patient experienced symptoms of fatigue and weakness due to hypocalcemia.
  • Treatment with calcium and calcitriol improved the patient's calcium levels and symptoms.

Implications:

  • This case highlights a potential immune-mediated adverse effect of pembrolizumab.
  • Prompt diagnosis and management of pembrolizumab-induced hypoparathyroidism are essential.
  • Further research is needed to understand the incidence and mechanisms of this side effect.